Audit 44719

FY End
2022-09-30
Total Expended
$199.32M
Findings
0
Programs
9
Organization: Pikeville Medical Center, Inc. (KY)
Year: 2022 Accepted: 2023-06-27
Auditor: Pya PC

Organization Exclusion Status:

Checking exclusion status...

Contacts

Name Title Type
Q1AJKQPTFLF9 Michelle Hagy Auditee
6062183501 Matt Stuart Auditor
No contacts on file

Notes to SEFA

Title: CONTINGENCIES Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards includes the federal loan and grant activity of Pikeville Medical Center and subsidiaries (the Hospital) and is presented on the accrual basis of accounting. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in this schedule may differ from amounts presented in, or used in the preparation of, the consolidated financial statements. Loan Balance Outstanding: There were no proceeds received or expended by the Hospital under the Community Facilities program during the year ended September 30, 2022. The expenditures reported on the Schedule of Expenditures of Federal awards represent the total balance of the loans outstanding at October 1, 2021 of $195,453,687. The total balance of the loans outstanding as of September 30, 2022 was $191,916,897. De Minimis Rate Used: N Rate Explanation: The Hospital has elected not to use the 10-percent de minimis cost rate allowed under the Uniform Guidance. The Hospitals federal programs are subject to financial and compliance audits by grantor agencies which, if instances of material noncompliance are found, may result in disallowed expenditures and affect the Hospitals continued participation in specific programs. The amount, if any, of expenditures which may be disallowed by the grantor agencies cannot be determined at this time, although the Hospital expects such amounts, if any, to be immaterial.
Title: PROVIDER RELIEF FUND Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards includes the federal loan and grant activity of Pikeville Medical Center and subsidiaries (the Hospital) and is presented on the accrual basis of accounting. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations (CFR) Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Therefore, some amounts presented in this schedule may differ from amounts presented in, or used in the preparation of, the consolidated financial statements. Loan Balance Outstanding: There were no proceeds received or expended by the Hospital under the Community Facilities program during the year ended September 30, 2022. The expenditures reported on the Schedule of Expenditures of Federal awards represent the total balance of the loans outstanding at October 1, 2021 of $195,453,687. The total balance of the loans outstanding as of September 30, 2022 was $191,916,897. De Minimis Rate Used: N Rate Explanation: The Hospital has elected not to use the 10-percent de minimis cost rate allowed under the Uniform Guidance. As discussed in Note O to the accompanying consolidated financial statements, the Hospital received a significant amount of funding from the Coronavirus Aid, Relief, and Economic Security Act Provider Relief Fund (PRF) program. Expenditures under this program are subject to the Uniform Guidance. In accordance with the 2022 Compliance Supplement, PRF amounts received during the year ended September 30, 2022 that were available to be used by December 31, 2022 will be included in the Schedule of Expenditures of Federal Awards as of September 30, 2023. No amounts were included in the Schedule of Expenditures of Federal Awards as of September 30, 2022. Under current Department of Health and Human Services guidelines, the Hospital reported on expenditures of Provider Relief Funds received during the year ended September 30, 2022 on or before March 31, 2023.